Pancuronium bromide

2D Structure
CID 27350
IUPAC Name [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-10,13-dimethyl-2,16-bis(1-methylpiperidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate dibromide
InChI InChI=1S/C35H60N2O4.2BrH/c1-24(38)40-32-21-26-13-14-27-28(35(26,4)23-31(32)37(6)19-11-8-12-20-37)15-16-34(3)29(27)22-30(33(34)41-25(2)39)36(5)17-9-7-10-18-36;;/h26-33H,7-23H2,1-6H3;2*1H/q+2;;/p-2/t26-,27+,28-,29-,30-,31-,32-,33-,34-,35-;;/m0../s1
InChI Key NPIJXCQZLFKBMV-YTGGZNJNSA-L
Canonical SMILES None
Isomeric SMILES None
Molecular Formula C35H60Br2N2O4
Molecular Weight 732.7
synonyms ['PANCURONIUM BROMIDE', '15500-66-0', 'Pancuronium dibromide', 'Mioblock', 'Bromuro de pancuronio', 'Bromure de pancuronium', 'Pancuronii bromidum', 'bromurex', 'ORG NA 97', 'ORG-NA 97', 'ORG-NA-97', 'U9LY9Y75X2', 'NA 97', '3alpha,17beta-Diacetoxy-2beta,16beta-dipiperidino-5alpha-androstane dimethobromide', '2beta,16beta-Dipiperidino-5alpha-androstane-3alpha,17beta-diol diacetate dimethobromide', 'NSC-293162', 'CHEBI:7908', 'DTXSID9023415', '3-alpha,17-beta-Diacetoxy-2-beta,16-beta-dipiperidino-5-alpha-androstane dimethobromide', '5alpha-Androstan-3alpha,17beta-diol, 2beta,16beta-dipipecolinio-, dibromide, diacetate', "Piperidinium, 1,1'-((2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)androstane-2,16-diyl)bis(1-methyl-, dibromide", "Piperidinium, 1,1'-(3alpha,17beta-dihydroxy-5alpha-androstan-2beta,16beta-ylene)bis(1-methyl-, dibromide, diacetate", 'Bromide, Pancuronium', 'pancuronium (cation)', '3alpha,17beta-diacetoxy-2beta,16beta-bis(1-methylpiperidinium-1-yl)-5alpha-androstane dibromide', "Piperidinium, 1,1'-((2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)androstane-2,16-diyl)bis(1-methyl)-, dibromide", 'NSC293162', 'panchronio bromuro', 'RefChem:56986', 'M03AC01', 'DTXCID101768515', "1,1'-(3alpha,17beta-Diacetoxy-5alpha-androstan-2beta,16beta-diyl)bis(1-methylpiperidinium) dibromide", '239-532-5', 'Pavulon', 'Pancuronium (dibromide)', 'MFCD00079223', 'C35H60Br2N2O4', "1,1'-((2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-3,17-diacetoxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-2,16-diyl)bis(1-methylpiperidin-1-ium) bromide", 'Bromure de pancuronium [INN-French]', 'Bromuro de pancuronio [INN-Spanish]', '(2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)-2,16-bis(1-methylpiperidinium-1-yl)androstane dibromide', 'HSDB 3244', 'Pancuronii bromidum [INN-Latin]', 'EINECS 239-532-5', 'NSC 293162', 'UNII-U9LY9Y75X2', '15500-66-0 (bromide)', 'Pavulon (TN)', 'Pancuronium bromide CRS', 'NCGC00163232-01', 'Pancuronium bromide [USAN:USP:INN:BAN:JAN]', 'CAS-15500-66-0', "1,1'-(3,17-Bis(acetyloxy)androstane-2,16-diyl)bis(1-methylpiperidinium) dibromide", '2beta,16beta-Dipiperidino-5alpha-androstane-3alpha,17beta-dioldiacetatedimethobromide', 'SCHEMBL41185', "1,1'-(3alpha,17beta-Bis(acetyloxy)-5alpha-androstane-2beta,16beta-diyl)bis(1-methylpiperidinium) dibromide", "1,1'-(3alpha,17beta-Dihydroxy-5alpha-androstan-2beta,16beta-ylene)bis(1-methylpiperidinium) dibromide diacetate", "Piperidinium, 1,1'-(2-beta,16-beta-(3-alpha,17-beta-dihydroxy-5-alpha-androstanylene))bis(1-methyl-, dibromide, diacetate", 'DTXCID403415', 'orb1310878', 'CHEMBL1200757', 'PANCURONIUM BROMIDE [MI]', 'HY-B0429R', 'PANCURONIUM BROMIDE [INN]', 'PANCURONIUM BROMIDE [JAN]', 'Vecuronium Bromide EP Impurity B', 'NPIJXCQZLFKBMV-YTGGZNJNSA-L', 'GLXC-03040', 'HMS1571O09', 'HMS2098O09', 'HMS3262B16', 'HMS3715O09', 'HMS3884P21', 'PANCURONIUM BROMIDE [HSDB]', 'PANCURONIUM BROMIDE [USAN]', 'PANCURONIUM BROMIDE [VANDF]', 'HY-B0429', 'Pancuronium (dibromide) (Standard)', 'PANCURONIUM BROMIDE [MART.]', 'Tox21_112033', 'Tox21_500887', 'EBC-11131', 'PANCURONIUM BROMIDE [USP-RS]', 'PANCURONIUM BROMIDE [WHO-DD]', 's2497', 'AKOS037515715', 'Pancuronium bromide (JP18/USP/INN)', 'CCG-221034', 'CCG-222191', 'FB26747', 'LP00887', 'NCGC00261572-01', 'PANCURONIUM BROMIDE [ORANGE BOOK]', 'BS-15969', 'PANCURONIUM BROMIDE [EP MONOGRAPH]', 'PANCURONIUM BROMIDE [USP MONOGRAPH]', 'EU-0100887', "1,1'-([2beta,3alpha,5alpha,16beta,17beta]-3,17-Bis[acetyloxy]androstane-2,16-diyl)bis(1-methylpiperidinium) dibromide", 'Pancuronium bromide for system suitability CRS', 'A12098', 'D00492', 'P 1918', 'SR-01000000127', 'SR-01000076059', 'SR-01000000127-3', 'SR-01000076059-1', 'Q27107612', 'Vecuronium Bromide EP Impurity B; Pancuronium Bromide', 'Pancuronium bromide, European Pharmacopoeia (EP) Reference Standard', 'Pancuronium bromide, United States Pharmacopeia (USP) Reference Standard', 'VECURONIUM BROMIDE IMPURITY, PANCURONIUM BROMIDE- [USP IMPURITY]', 'Pancuronium bromide for system suitability, European Pharmacopoeia (EP) Reference Standard', '[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetoxy-10,13-dimethyl-2,16-bis(1-methylpiperidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate;dibromide', '[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-Acetyloxy-10,13-dimethyl-2,16-bis(1-methylpiperidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate;bromide', '[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-10,13-dimethyl-2,16-bis(1-methylpiperidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate;dibromide', "1,1'-((2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-3,17-Diacetoxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-2,16-diyl)bis(1-methylpiperidin-1-ium) bromi", "1,1'-(3.ALPHA.,17.BETA.-DIHYDROXY-5.ALPHA.-ANDROSTAN-2.BETA.,16.BETA.-YLENE)BIS(1-METHYLPIPERIDINIUM)DIBROMIDE DIACETATE", "1,1'-(3alpha,17beta-Dihydroxy-2beta,5alpha-androstan-2beta,16beta-ylene) bis[1-methylpiperidinium] diacetate dibromide", "1,1'-[(2?,3?,5?,16?,17?)-3,17-Bis(acetyloxy)androstane-2,16-diyl]bis(1-methylpiperidinium) dibromide", '2.beta.,16.beta.-Dipiperidino-5.alpha.-androstane-3.alpha.,17.beta.-diol diacetate dimethobromide', "PIPERIDINIUM, 1,1'-((2.BETA.,3.ALPHA.,5.ALPHA.,16.BETA.,17.BETA.)-3,17-BIS(ACETYLOXY)ANDROSTANE-2,16-DIYL)BIS(1-METHYL)-, DIBROMIDE"]

From Pubchem